You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

psychotropic drug

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Valproic Acid Therapy in Patients With Neurological Disorders

Completed
  • Neurological Disorders
  • Educational intervention
  • (no location specified)
Apr 14, 2023

Emergence Agitation Trial in Shanghai (Esketamine, Sevoflurane)

Recruiting
  • Emergence Agitation
  • Shanghai, Shanghai, China
    Anesthesiology Department of Affiliated Eye and ENT Hospital, Fu
Dec 3, 2022

Depression, Schizophrenia, Bipolar Disorder Trial

Not yet recruiting
  • Depression
  • +7 more
    • (no location specified)
    Nov 1, 2023

    MDD Trial in Boston (GeneSight Psychotropic test, Canadian Network for Mood and Anxiety Treatment (CANMAT) Best Practice

    Completed
    • Major Depressive Disorder
    • GeneSight Psychotropic test
    • Canadian Network for Mood and Anxiety Treatment (CANMAT) Best Practice Guidelines
    • Boston, Massachusetts
      Massachusetts General Hospital
    Apr 5, 2022

    FIbrosis and Steatosis in Patients With Psychiatric Illness

    Completed
    • Severe Bipolar I Disorder (Diagnosis)
    • +3 more
    • Fibroscan
    • Limoges, France
      Centre Hospitalier Esquirol
    Jul 20, 2023

    Inpatient Evaluation of Adults With Schizophrenia

    Recruiting
    • Schizophrenia
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    Schizophrenia, Medication Adherence, Medication Compliance Trial in Taipei City (The theory based integrated program)

    Completed
    • Schizophrenia
    • +2 more
    • The theory based integrated program
    • Taipei City, Taiwan
      National Taipei University of Nursing and Health Sciences
    Apr 18, 2023

    Staff Attitude, Dementia Trial in Iowa City, Kansas City (Changing Talk Online (CHATO))

    Completed
    Has Results
    • Staff Attitude
    • Dementia
    • Changing Talk Online (CHATO)
    • Iowa City, Iowa
    • +1 more
    Aug 30, 2021

    Pharmacogenomics, Depression Trial (Genomic analysis of antidepressants)

    Not yet recruiting
    • Pharmacogenomics
    • Depression
    • Genomic analysis of antidepressants
    • (no location specified)
    Dec 29, 2022

    Schizophrenia and Related Disorders, MDD, Bipolar Depression Trial (Clozapine, Esketamine Nasal Product, Escitalopram)

    Not yet recruiting
    • Schizophrenia and Related Disorders
    • +2 more
    • (no location specified)
    Jan 12, 2023

    COPD Trial in Lodève, Osséja (Hypnosis intervention focused on the emotional dimension of the dyspnea)

    Recruiting
    • Chronic Obstructive Pulmonary Disease
    • Hypnosis intervention focused on the emotional dimension of the dyspnea
    • Lodève, France
    • +1 more
    Feb 7, 2022

    Dementia, Home-dwelling, Caregiver Trial in Bergen (LIVE)

    Active, not recruiting
    • Dementia
    • +2 more
    • LIVE
    • Bergen, Norway
      University of Bergen
    Jun 13, 2022

    Respiratory Disorder, Lung Infection Trial in France (Virtual reality headset)

    Not yet recruiting
    • Respiratory Disorder
    • Lung Infection
    • Virtual reality headset
    • Aix-en-Provence, France
    • +3 more
    Jul 26, 2023

    Pharmacokinetics, Tolerability, Safety Trial in Warngau (AP707)

    Completed
    • Pharmacokinetics
    • +2 more
    • Warngau, Bavaria, Germany
      Phase I Unit of CannaXan GmbH
    Jul 25, 2022

    Hypercapnia, Ventilatory Depression Trial in West Bend (Oxycodone and Midazolam, Oxycodone, Paroxetine, and Quetiapine)

    Completed
    • Hypercapnia
    • Ventilatory Depression
    • Oxycodone and Midazolam
    • Oxycodone, Paroxetine, and Quetiapine
    • West Bend, Wisconsin
      Spaulding Clinical Research
    Aug 16, 2021

    Bipolar Disorder I, Bipolar II Disorder, Bipolar I Disorder Trial in Stanford (LCHF Ketogenic Diet)

    Not yet recruiting
    • Bipolar Disorder I
    • +14 more
    • LCHF Ketogenic Diet
    • Stanford, California
      Stanford University School of Medicine
    Jan 21, 2023

    Dementia Trial (doll therapy)

    Not yet recruiting
    • Dementia
    • doll therapy
    • (no location specified)
    Jan 19, 2023

    Obesity, Ketogenic Dieting, Metabolic Syndrome Trial in Stanford (LCHF, Ketogenic Diet)

    Completed
    • Obesity
    • +7 more
    • LCHF, Ketogenic Diet
    • Stanford, California
      Stanford University Department of Psychiatry & Behavioral Scienc
    Dec 6, 2022

    Post-traumatic Stress Disorder, Cocaine Use Disorder Trial in Zürich (Imagery, Minocycline, Placebo)

    Recruiting
    • Post-traumatic Stress Disorder
    • Cocaine Use Disorder
    • Imagery
    • +2 more
    • Zürich, Switzerland
      Psychiatric University Hospital Zurich, University of Zurich
    Jun 5, 2023

    Opioid Use Disorder Trial in Overland Park (Morphine Sulfate)

    Recruiting
    • Opioid Use Disorder
    • Morphine Sulfate
    • Overland Park, Kansas
      AltaSciences
    Feb 17, 2022

    Major Depression Trial in United States (Pharmacogenetic Test)

    Completed
    • Major Depression
    • Pharmacogenetic Test
    • North Little Rock, Arkansas
    • +23 more
    Apr 13, 2022

    Adolescent Trial in Hong Kong (A video competition, A training workshop, A mass promotional campaign)

    Not yet recruiting
    • Adolescent
    • A video competition
    • +2 more
    • Hong Kong, Hong Kong, China, Hong Kong
      Ka Yan HO
    May 20, 2021

    Epilepsy Trial (Pharmacist-led Cognitive Behavioral therapy)

    Not yet recruiting
    • Epilepsy
    • Pharmacist-led Cognitive Behavioral therapy
    • (no location specified)
    Sep 12, 2023

    Dementia With Behavioral Disturbance Trial in Geneva (Cannabis Sativa Oil, Placebo)

    Not yet recruiting
    • Dementia With Behavioral Disturbance
    • Cannabis Sativa Oil
    • Placebo
    • Geneva, Switzerland
      FAHPA
    Jun 22, 2022

    Schizophrenia Trial in Cleveland (Customized Adherence Enhancement for Schizophrenia (CAE-S), Enhanced Treatment as Usual

    Not yet recruiting
    • Schizophrenia
    • Customized Adherence Enhancement for Schizophrenia (CAE-S)
    • Enhanced Treatment as Usual (eTAU)
    • Cleveland, Ohio
      University Hospitals Cleveland Medical Center
    Sep 25, 2023